Cargando…

A potential role of PI3K inhibition in radiotherapy of glioblastoma multiforme

Detalles Bibliográficos
Autores principales:	Langhans, Julia, Schneele, Lukas, Debatin, Klaus-Michael, Westhoff, Mike-Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715183/ http://dx.doi.org/10.1186/2194-7791-2-S1-A18

Ejemplares similares

Inhibition of PI3K signalling increases the efficiency of radiotherapy in glioblastoma cells
por: Hasslacher, Sebastian, et al.
Publicado: (2018)

A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy
por: Ströbele, Stephanie, et al.
Publicado: (2015)

The effects of PI3K-mediated signalling on glioblastoma cell behaviour
por: Langhans, Julia, et al.
Publicado: (2017)

A critical evaluation of PI3K inhibition in Glioblastoma and Neuroblastoma therapy
por: Westhoff, Mike-Andrew, et al.
Publicado: (2014)

Taxifolin Targets PI3K and mTOR and Inhibits Glioblastoma Multiforme
por: Yao, Weiqi, et al.
Publicado: (2021)

Sequential Dosing in Chemosensitization: Targeting the PI3K/Akt/mTOR Pathway in Neuroblastoma
por: Westhoff, Mike-Andrew, et al.
Publicado: (2013)

PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme Cells
por: Udawant, Shreya, et al.
Publicado: (2021)

Erythema multiforme induced by clindamycin diagnosed by patch test
por: Saliba, Bruna Gama, et al.
Publicado: (2015)

BEZ235 impairs gastric cancer growth by inhibition of PI3K/mTOR in vitro and in vivo
por: Füreder, Thorsten, et al.
Publicado: (2010)

Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?”
por: Glynn, Aisling M., et al.
Publicado: (2019)

PI3Kδ is indispensable for CTL-mediated cytotoxicity
por: Putz, Eva M, et al.
Publicado: (2011)

Comment in Response to “Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy etc. by B. Kaina”
por: Westhoff, Mike-Andrew, et al.
Publicado: (2020)

Immune phenotypes predict survival in patients with glioblastoma multiforme
por: Mostafa, Haouraa, et al.
Publicado: (2016)

Temozolomide and Other Alkylating Agents in Glioblastoma Therapy
por: Strobel, Hannah, et al.
Publicado: (2019)

Improved hippocampal dose with reduced margin radiotherapy for glioblastoma multiforme
por: Ali, Arif N, et al.
Publicado: (2014)

Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development
por: Zhao, Hua-fu, et al.
Publicado: (2017)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma in vitro and in vivo
por: Werzowa, Johannes, et al.
Publicado: (2010)

Characterization and identification of leukemia initiating cells in pediatric acute lymphoblastic leukemia
por: Trentin, Luca, et al.
Publicado: (2014)

Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical ALL xenograft model in vivo
por: Schirmer, Melanie, et al.
Publicado: (2014)

Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme
por: Choi, Jinyeong, et al.
Publicado: (2020)

Cancer therapy: know your enemy?
por: Westhoff, Mike-Andrew, et al.
Publicado: (2014)

How to Respond to Misinformation From the Anti-Vaccine Movement
por: Westhoff, Mike-Andrew, et al.
Publicado: (2023)

Diisothiocyanate-Derived Mercapturic Acids Are a Promising Partner for Combination Therapies in Glioblastoma
por: Xu, Pengfei, et al.
Publicado: (2022)

ACT-16 THE POTENTIAL OF HYPOFRACTIONATED RADIOTHERAPY AND BEVACIZUMAB FOR GLIOBLASTOMA TREATMENT
por: Hata, Nobuhiro, et al.
Publicado: (2019)

ETMM-09 TARGETING GLIOBLASTOMA MULTIFORME METABOLISM AT THE INVASIVE TUMOR FRONT
por: Garcia, Joseph H, et al.
Publicado: (2021)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

N-cadherin-ERα-Src signal models mediate the synergistic potentiation of activation of PI3K/Akt signal pathway in injured dopaminergic neurons by GDNF and E2
por: Shi, Zixiao, et al.
Publicado: (2012)

Erythema multiforme provoked by radiotherapy
por: Machoń, Natalia Joanna, et al.
Publicado: (2023)

Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme
por: Mishra, Vishnu S., et al.
Publicado: (2020)

Paucimannosidic glycoepitopes inhibit tumorigenic processes in glioblastoma multiforme
por: Becker, Yvonne, et al.
Publicado: (2019)

Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme
por: Greer, Liana, et al.
Publicado: (2017)

Feasibility of extreme dose escalation for glioblastoma multiforme using 4π radiotherapy
por: Nguyen, Dan, et al.
Publicado: (2014)

Inducing cell death in Glioblastoma
por: Tappuni, Shahed, et al.
Publicado: (2015)

TLR2 and TLR4 signaling in macrophages is negatively regulated by a Lyn-PI3K module and promoted by SHIP1
por: Keck, S, et al.
Publicado: (2009)

The limitations of targeting MEK signalling in Glioblastoma therapy
por: Selvasaravanan, Karthika D., et al.
Publicado: (2020)

FAM72, Glioblastoma Multiforme (GBM) and Beyond
por: Ho, Nguyen Thi Thanh, et al.
Publicado: (2021)

Simultaneously double infection of oncolytic viruses leads to addition of cell death induction in glioblastoma cell lines
por: Ehrhardt, Michael, et al.
Publicado: (2015)

The anti-addiction drug ibogaine inhibits cardiac ion channels: a study to assess the drug’s proarrhythmic potential
por: Koenig, Xaver, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_amjsd41qjbs2i8ghdukdlvmdv1